The Manufacturers Life Insurance Company Lowers Stock Holdings in Bath & Body Works, Inc. $BBWI

The Manufacturers Life Insurance Company reduced its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 17.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,380,404 shares of the company’s stock after selling 301,153 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Bath & Body Works were worth $25,772,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in BBWI. Global Retirement Partners LLC purchased a new stake in Bath & Body Works in the 4th quarter valued at about $31,000. Activest Wealth Management purchased a new position in shares of Bath & Body Works during the 4th quarter worth about $32,000. Geneos Wealth Management Inc. lifted its holdings in shares of Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC lifted its holdings in shares of Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares during the period. Finally, Danske Bank A S acquired a new stake in shares of Bath & Body Works in the third quarter worth approximately $39,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $20.13 on Friday. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $32.32. The stock has a market capitalization of $4.06 billion, a P/E ratio of 5.66, a PEG ratio of 1.97 and a beta of 1.38. The stock has a 50-day simple moving average of $20.15 and a 200-day simple moving average of $20.37.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The firm had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter in the prior year, the company earned $0.49 EPS. The company’s revenue was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Analysts predict that Bath & Body Works, Inc. will post 2.63 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, June 5th. This represents a $0.80 annualized dividend and a dividend yield of 4.0%. Bath & Body Works’s dividend payout ratio is presently 22.47%.

Analysts Set New Price Targets

BBWI has been the subject of a number of recent analyst reports. Barclays lowered their target price on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a report on Thursday, May 28th. The Goldman Sachs Group downgraded shares of Bath & Body Works from a “neutral” rating to a “sell” rating and cut their price target for the stock from $23.00 to $19.00 in a research note on Wednesday, July 8th. Weiss Ratings upgraded shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 9th. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. Finally, Morgan Stanley restated an “equal weight” rating and set a $22.00 price objective on shares of Bath & Body Works in a report on Monday, July 6th. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Bath & Body Works presently has a consensus rating of “Hold” and a consensus price target of $21.93.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.